Avvaru Susmita1, Naga Neelima Devi Kolli2, Sridhar Meka2, Srinivas Pandi Chakravarthi2, Vivekanand Sabanna Kattimani3, Krishna Prasad Lingamaneni4, Latheef Saheb Shaik1. 1. Postgraduate Student, Department of Oral and Maxillofacial Surgery, Sibar Institute of Dental Sciences , Guntur, Andhra Pradesh, India . 2. Professor, Department of Oral and Maxillofacial Surgery, Sibar Institute of Dental Sciences , Guntur, Andhra Pradesh, India . 3. Reader, Department of Oral and Maxillofacial Surgery, Sibar Institute of Dental Sciences , Guntur, Andhra Pradesh, India . 4. Professor and Head, Department of Oral and Maxillofacial Surgery, Sibar Institute of Dental Sciences , Guntur, Andhra Pradesh, India .
Abstract
INTRODUCTION: The pursuit of youth and beauty has undergone a resurgence of interest which is evidenced by increasing cosmetic procedures. Botulinum Toxin Type A (Botox) is one among the many procedures invented for facial rejuvenation which denervates certain muscles of facial expression responsible for facial wrinkles. It has been applied in the forehead, glabella, lateral canthal area and neck. In maxillofacial area hyperactive forehead wrinkles show sagging. AIM: This study was aimed to clinically evaluate the efficacy of Botox injection in the elimination of hyperdynamic forehead wrinkles and the objectives were to compare pre-operative and post-operative improvement in the number of wrinkles, photographic grading and patient satisfaction responses after 1st week, 4th week and 16th week. MATERIALS AND METHODS: A total of 10 patients were randomly included in the present study who were cooperative, motivated and aesthetically conscious with moderate to severe forehead wrinkles. Assessment was performed clinically, photographically (using standardized photographs) and patient satisfaction responses were recorded at 1st week, 4th week and 16th week. RESULTS: The study showed a significant difference in the elimination of wrinkles at rest and in action when assessed at 1st week and 4th week and it was consistent at 16th week. The patient showed positive satisfaction response without ptosis of the upper eyelid. CONCLUSION: Treatment with Botox is simple, safe and an effective modality for reduction of forehead wrinkles. It offers an alternative management in a cost-effective way when compared to surgical procedures.
INTRODUCTION: The pursuit of youth and beauty has undergone a resurgence of interest which is evidenced by increasing cosmetic procedures. Botulinum Toxin Type A (Botox) is one among the many procedures invented for facial rejuvenation which denervates certain muscles of facial expression responsible for facial wrinkles. It has been applied in the forehead, glabella, lateral canthal area and neck. In maxillofacial area hyperactive forehead wrinkles show sagging. AIM: This study was aimed to clinically evaluate the efficacy of Botox injection in the elimination of hyperdynamic forehead wrinkles and the objectives were to compare pre-operative and post-operative improvement in the number of wrinkles, photographic grading and patient satisfaction responses after 1st week, 4th week and 16th week. MATERIALS AND METHODS: A total of 10 patients were randomly included in the present study who were cooperative, motivated and aesthetically conscious with moderate to severe forehead wrinkles. Assessment was performed clinically, photographically (using standardized photographs) and patient satisfaction responses were recorded at 1st week, 4th week and 16th week. RESULTS: The study showed a significant difference in the elimination of wrinkles at rest and in action when assessed at 1st week and 4th week and it was consistent at 16th week. The patient showed positive satisfaction response without ptosis of the upper eyelid. CONCLUSION: Treatment with Botox is simple, safe and an effective modality for reduction of forehead wrinkles. It offers an alternative management in a cost-effective way when compared to surgical procedures.
Authors: D H Lee; S M Kang; A Feneran; C S Youn; J K Kim; S Cho; C H Won; S E Chang; M W Lee; J H Choi; K C Moon Journal: J Eur Acad Dermatol Venereol Date: 2012-10-03 Impact factor: 6.166